IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)
about
The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agentsComprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortiumUnraveling insulin-like growth factor binding protein-3 actions in human diseaseInsidious changes in stromal matrix fuel cancer progressionIs there a role for IGF-1 in the development of second primary cancers?Genomic interaction profiles in breast cancer reveal altered chromatin architecture.IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studiesMetabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control studyIGF-1 regulates Cyr61 induced breast cancer cell proliferation and invasion.Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort.Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts.The proliferating role of insulin and insulin-like growth factors in cancer.Genetic and dietary determinants of insulin-like growth factor (IGF)-1 and IGF binding protein (BP)-3 levels among Chinese women.Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptorExpression of IGF1R in normal breast tissue and subsequent risk of breast cancerThe association of alcohol consumption with mammographic density in a multiethnic urban populationDevelopmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice.Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.IGFBP3 mRNA expression in benign and malignant breast tumorsThe Insulin-like Growth Factor Axis, Adipokines, Physical Activity, and Obesity in Relation to Breast Cancer Incidence and RecurrenceEffects of High-Order Interactions among IGFBP-3 Genetic Polymorphisms, Body Mass Index and Soy Isoflavone Intake on Breast Cancer Susceptibility.Agreement between circulating IGF-I, IGFBP-1 and IGFBP-3 levels measured by current assays versus unavailable assays previously used in epidemiological studies.Neonatal growth and breast cancer risk in adulthood.Differential effects of various progestogens on metabolic risk factors for breast cancer.Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy womenInsulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.A prospective study of age-specific physical activity and premenopausal breast cancer.IGF gene polymorphisms and breast cancer in African-American and Hispanic women.Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancerEffects of tomato- and soy-rich diets on the IGF-I hormonal network: a crossover study of postmenopausal women at high risk for breast cancer.Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium.Targeting the IGF1 axis in cancer proliferation.Challenges to the control of breast cancer in a small developing country.Identifying population-based approaches to lower breast cancer risk.Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis.
P2860
Q24304487-2773D68B-F287-4587-B53E-DA939253D129Q24614574-4D4E8D77-FA8B-4194-B184-1551A15A8763Q24650060-C54D30F6-ABC4-4D8E-B903-D8C817D4FD99Q26851261-41D1E069-A578-4D84-8D51-FF57330F369EQ28069262-4DA8FA80-1F0B-4981-9CC7-1A86134B84D4Q31137734-C7506949-3A95-4AF2-BC18-B0D93B339340Q33348545-BAAD95F4-8005-415A-BBD7-C5FEA30E2955Q33569159-FD69D893-FE94-416C-A96C-59F071C49B05Q33578887-AB407603-A149-4456-A84C-2DDCC8F7E6A9Q33643001-B17908AF-2F23-47C4-B692-AC128DCA5ED1Q33952555-45694482-E272-42D6-85BB-30BB235A4A4CQ34036279-4A8DED0F-BDC5-40F1-9D25-CEB430E8C695Q34078803-2F868517-5711-4A71-AB40-EB47D5C96909Q34145178-20E2D195-98F8-428E-9CBD-B103E0BA942BQ34172625-7A6A1AA0-38DE-4C70-A91F-7529B1F8792AQ34294117-2903958D-9DCB-47F0-866C-42104DC6DD12Q34796287-515AC62E-2298-4777-9495-E49032DAEFDBQ35048307-40806FCE-EB25-45FF-9A2E-C742D1D0A2B0Q35218975-72F5D9D4-3CF4-4F97-9911-F5448F63AFA5Q35640525-6F6DDF72-A7F4-49C8-AEA9-E496A5091DF6Q35749326-3A3C3B1E-9DDD-414B-A546-28C67380CAB6Q35749398-E5AA0FEC-97F9-45E9-AB67-4AD8D17C28B7Q35914914-57035F38-071C-4CCC-A56F-7272D870EC42Q36134212-10114BE8-A6CC-41FA-9D49-E992C5609414Q36494391-EC8E337A-7828-46DE-AA14-01CD2CF7EE56Q36965021-6FA06016-C307-46AE-8BCD-3012315EFE84Q36974417-CCE40E3A-55C3-4878-8FA7-615B142C687CQ37078710-C983721D-DC75-44C6-B73D-B026B356AAFCQ37090766-D23A8D6D-5FA7-44C6-873F-91022E3D0A3AQ37094736-52A5B367-BAB1-4AB0-B2BD-5D6940C801EEQ37095826-38F12E81-8723-4732-B162-559DE4C09B3BQ37151431-C2D368AB-87AE-43DC-8804-2791B283BDDAQ37334904-EE0629D3-EB90-4BE7-9AA5-9FF99A061DB8Q37418923-0FA74BEE-62E0-44C5-86CA-EB115C90AB15Q37441195-75503DF8-88AF-486E-989E-C670FF23A20AQ37482022-44F4D47B-FB72-4222-915D-BA36289C0601Q37575541-C9510397-7CDD-480B-8530-D510645C9D3BQ37577873-AD24641E-15AC-4B93-8B18-635DF3A59FF5Q37643427-BA2BDEFC-BD49-4FE9-A6F9-19B597520293Q38069964-0B3BFDD4-4651-409F-AFA3-34BE218D13C9
P2860
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)
description
im Juni 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2006
@uk
name
IGF-I, IGFBP-3 and breast canc ...... to Cancer and Nutrition (EPIC)
@en
IGF-I, IGFBP-3 and breast canc ...... to Cancer and Nutrition (EPIC)
@nl
type
label
IGF-I, IGFBP-3 and breast canc ...... to Cancer and Nutrition (EPIC)
@en
IGF-I, IGFBP-3 and breast canc ...... to Cancer and Nutrition (EPIC)
@nl
prefLabel
IGF-I, IGFBP-3 and breast canc ...... to Cancer and Nutrition (EPIC)
@en
IGF-I, IGFBP-3 and breast canc ...... to Cancer and Nutrition (EPIC)
@nl
P2093
P50
P356
P1476
IGF-I, IGFBP-3 and breast canc ...... to Cancer and Nutrition (EPIC)
@en
P2093
A Lukanova
A Trichopoulou
C A Gonzalez
C H van Gils
D E Grobbee
F Clavel-Chapelon
P304
P356
10.1677/ERC.1.01150
P50
P577
2006-06-01T00:00:00Z